Research / WTW / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-055453 Insurance
Cash 13th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.cash
$1.2B · CORE · VALID
Debt 63th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_debt
$5.2B · OPTIONAL · VALID
Net-income growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.net_income
-28.42% · CORE · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
10.17% · CORE · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 14 states Self-history eligible
Sep 30, 2022 0/4 normalized Level 3 Dec 31, 2022 0/4 normalized Level 3 Mar 31, 2023 0/4 normalized Level 3 Jun 30, 2023 0/4 normalized Level 3 Sep 30, 2023 2/4 normalized Level 3 Dec 31, 2023 2/4 normalized Level 3 Mar 31, 2024 2/4 normalized Level 3 Jun 30, 2024 2/4 normalized Level 3 Sep 30, 2024 4/4 normalized Level 3 Dec 31, 2024 4/4 normalized Level 3 Mar 31, 2025 4/4 normalized Level 3 Jun 30, 2025 4/4 normalized Level 3 Mar 31, 2026 4/4 normalized Level 3 Jun 30, 2026 4/4 normalized Level 4 Period transition
What moved in the state? Cash Decreased
Previous $1.6B
Current $1.2B
Delta -$355.0M Debt Decreased
Previous $5.5B
Current $5.2B
Delta -$250.0M Earnings Growth Decreased
Previous -13.76%
Current -28.42%
Delta -14.66% Revenue Growth Increased
Previous 7.29%
Current 10.17%
Delta 2.87% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.